Drotrecogin Alfa (activated)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AD10

CAS registry number (Chemical Abstracts Service)

0098530-76-8

Chemical Formula

C2071-H3165-N581-O640-S31

Molecular Weight

47438

Therapeutic Category

Anticoagulant: Thrombin inhibitor

Chemical Name

Blood-coagulation factor XIV (human) (WHO)

Foreign Names

• Drotrecoginum alfa (activatum) (Latin)
• Drotrecogin alfa (aktiviert) (German)
• Drotrécogine alfa (activé) (French)
• Drotrecogina alfa (activada) (Spanish)

Generic Names

• Drotrecogin Alfa (activated) (OS: BAN, USAN)
• Human activated protein C, recombinant (IS)
• LY 203638 (IS: Eli Lilly)
• Protein C human, recombinant (IS)
• Recombinant human activated protein C (IS)
• Rekombinantes humanes aktiviertes Protein C (rhAPC). (IS)
• rhAPC (IS)

Brand Names

• Xigris
  Eli Lilly, Canada; Eli Lilly, United Kingdom; Eli Lilly, Netherlands; Eli Lilly, Oman; Eli Lilly, South Africa; Eli Lilly NL B.V., Luxembourg; Lilly, Argentina; Lilly, Austria; Lilly, Australia; Lilly, Belgium; Lilly, Switzerland; Lilly, Chile; Lilly, Czech Republic; Lilly, Germany; Lilly, Denmark; Lilly, Spain; Lilly, Finland; Lilly, France; Lilly, Hong Kong; Lilly, Croatia (Hrvatska); Lilly, Hungary; Lilly, Ireland; Lilly, Israel; Lilly, India; Lilly, Iceland; Lilly, Italy; Lilly, Mexico; Lilly, Malaysia; Lilly, Norway; Lilly, New Zealand; Lilly, Poland; Lilly, Romania; Lilly, Russian Federation; Lilly, Sweden; Lilly, Singapore; Lilly, Slovenia; Lilly, Slovakia; Lilly, Turkey; Lilly, Taiwan; Lilly, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.